Director/Sr. Director, Business Development & Corporate Strategy Seal Beach, California, United States

Director/Sr. Director, Business Development & Corporate Strategy

Seal Beach, California, United States

WHO WE ARE :

At Dendreon,we’retransforming the battle against cancer with personalized immunotherapy. Our flagship product, PROVENGE® (sipuleucel-T) , was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancer,utilizinga patient’s own immune cells to fight the disease.

If you’re driven by the opportunity to make a meaningful impact on cancer patients’ lives, we invite you to join our team. With Immunotherapy Manufacturing Facilities in Seal Beach, CA, and Union City, GA, a talented team of scientific, clinical, regulatory, and corporate professionals based in Seal Beach, and a commercial organization operating across the United States, Dendreon continues to advance innovation in personalized cancer treatment.

CORE VALUES:

• Put Patients First: Every day is an opportunity to improve the lives of those living with cancer.
• Act with Integrity: We commit to transparency, honesty, and always doing what’s right.
• Build Trust: Trust is earned through candid, open communication and a collaborative approach.
• Raise the Bar: We embrace continuous improvement and innovation, always striving to elevate our people.
• Drive Results: We are accountable to each other and deliver success together.

WHO WE ARE :

At Dendreon, we’re transforming the battle against cancer with personalized immunotherapy. Our flagship product, PROVENGE® ( sipuleucel -T) , was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancer, utilizing a patient’s own immune cells to fight the disease.

If you’re driven by the opportunity to make a meaningful impact on cancer patients’ lives, we invite you to join our team. With Immunotherapy Manufacturing Facilities in Seal Beach, CA, and Union City, GA, a talented team of scientific, clinical, regulatory, and corporate professionals based in Seal Beach, and a commercial organization operating across the United States, Dendreon continues to advance innovation in personalized cancer treatment.

CORE VALUES:

• Put Patients First: Every day is an opportunity to improve the lives of those living with cancer.
• Act with Integrity: We commit to transparency, honesty, and always doing what’s right.
• Build Trust: Trust is earned through candid, open communication and a collaborative approach.
• Raise the Bar: We embrace continuous improvement and innovation, always striving to elevate our people.
• Drive Results: We are accountable to each other and deliver success together.

JOB SUMMARY:

The Director/ Senior Director of Business Development & Corporate Strategy will drive Dendreon’s growth through strategic partnerships, licensing, and corporate development initiatives. This role requires an experienced biotech or pharmaceutical business development leader with a track record of advancing innovative, late-stage (Phase II/III), first-in-class assets. The Director/ Senior Director will lead global opportunity sourcing, diligence, and deal execution, while partnering cross-functionally to evaluate international assets and collaborations, support CDMO business development, and engage with financial investment partners.

Responsibilities:

• Strategic Partnerships & Investment-Driven Growth
  • Serve as a key corporate strategist identifying high-impact opportunities for external innovation and investment.
  • Identify , evaluate, and lead strategic transactions and investments aligned with Dendreon’s business strategy, including first-in-class and differentiated therapeutic modalities (e.g., ADCs or other complex platforms).
• Biotech Business Development & Asset Acquisition
  • Lead the search, evaluation, and acquisition of innovative clinical- to commercial-stage therapeutic assets, with emphasis on late-stage (Phase II/III), first-in-class programs aligned with Dendreon’s core therapeutic areas, including immunotherapy, urology, and oncology.
  • Evaluate complex therapeutic modalities, including antibody-drug conjugates (ADCs) or similarly advanced platforms, assessing scientific differentiation, clinical risk, and commercial potential.
  • Conduct robust diligence with cross-functional support from Clinical, Regulatory, CMC, IP, Commercial, and Finance to drive informed decisions and maximize asset value.
  • Develop detailed market assessments, forecasts, valuation models, and scenario analyses for internal and external opportunities.
  • Partner closely with internal teams (R&D, Clinical, Regulatory, Commercial, Finance, Legal/IP) to perform scientific and commercial diligence, valuation modeling, and competitive landscape analyses.
• CDMO Strategy & Business Development
  • Build and execute a business development plan to position Dendreon’s manufacturing capabilities as a CDMO partner for emerging and established biotech clients.
  • Identify and engage prospective CDMO partners , from early-stage startups to mid-size biotechs , structuring proposals and partnerships that leverage Dendreon’s technical and operational strengths.
  • Collaborate with Technical Operations, Quality, and Regulatory to ensure operational readiness and partner alignment on timelines and technical feasibility.
  • Represent Dendreon at relevant CDMO and manufacturing conferences and in client-facing discussions.
• Deal Structuring, Negotiation & Execution
  • Lead the structuring , negotiation, and execution of term sheets and definitive agreements for BD and CDMO transactions.
  • Manage internal due diligence processes, coordinate with legal on contract development, and align stakeholders on deal terms and governance.
• Partner with the CEO and S enior L eadership T eam to refine corporate strategy and long-range planning.
• Prepare and present executive summaries, board materials, and strategic recommendations based on external opportunity assessments

JOB REQUIREMENTS:

Required Experience & Skills :

• 7-10+ years of progressive experience in business development in the biotech or pharmaceutical industry.
• Demonstrated ability to lead BD, M&A, licensing, or investment transactions from sourcing through execution.
• Advanced degree required : MBA, PhD, MD, or equivalent scientific or financial training.
• Strong understanding of complex therapeutic modalities, such as ADCs, biologics, cell therapies, or other advanced platforms.
• Deep financial acumen including valuation modeling, risk/return analysis, and deal structuring.
• Executive presence and excellent communication skills with ability to build trust internally and externally.
• Strong cross-functional leadership with proven ability to influence stakeholders across Clinical, Technical Ops, Regulatory, and Legal.
• Deal Sheet Required.
• Willingness to travel up to 50%+, including international travel.

Preferred Experience:

• Board-level exposure or experience presenting to board/investment committees.
• Direct experience supporting or leading CDMO strategy or partnerships.
• Strong network within the VC/PE community focused on early - to mid -stage biotech.
• Familiarity with oncology, immunotherapy, urology, or cellular immunotherapies. Prior operating experience within a biotech or biopharma company.
• Consulting or operating experience in high-growth biotech or commercial-stage biopharma environments.
• Global experience with international partnerships, particularly the biotech or pharmaceutical environments in China.
• Experience in venture capital, private equity, or investment banking within the life sciences industry .

Working Conditions and Physical Requirements:

• On - site in Seal Beach, CA. This position is NOT remote.
• This position operates in a professional office environment. This role routinely uses standard office equipment such as computers, phones, photocopiers, filing cabinets and fax machines.
• The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job.
• While performing the duties of this job, the employee is regularly required to talk or hear. The employee frequently is required to stand, walk; use hands to finger, handle or feel; and reach with hands and arms.

CA Compensation Range

$177,674 - $248,049 USD

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.

As set forth in Dendreon Pharmaceuticals LLC’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.

Voluntary Self-Identification of Disability

Form CC-305 Page 1 of 1 OMB Control Number Expires 07/31/2029

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at .

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

• Alcohol or other substance use disorder (not currently using drugs illegally)
• Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
• Blind or low vision
• Cancer (past or present)
• Cardiovascular or heart disease
• Celiac disease
• Cerebral palsy
• Deaf or serious difficulty hearing
• Diabetes
• Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
• Epilepsy or other seizure disorder
• Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
• Intellectual or developmental disability
• Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
• Missing limbs or partially missing limbs
• Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
• Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
• Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
• Partial or complete paralysis (any cause)
• Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
• Short stature (dwarfism)
• Traumatic brain injury

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.